Compare ARK Genomic Revolution ETF (ARKG) vs MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs MicroSectors FANG and Innovation 3X Leveraged ETN — how do they compare? ARK Genomic Revolution ETF trades at $40.98, while MicroSectors FANG and Innovation 3X Leveraged ETN trades at $28.21. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, MicroSectors FANG and Innovation 3X Leveraged ETN nearer its low. Which is the better fit depends on your goals.
| ARKG | FNGU | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $36.15 |
52-Week Low | $23.09 | $13.73 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FNGU trades at $28.64, up 0.77% on the day, with technical indicators showing a bullish trend from moving averages but caution from oscillators like the 6-day RSI at 95.66. Recent news highlights extreme volatility, with a 16% single-session drop reported on June 5, 2026, underscoring the leveraged ETN's high-risk nature. The asset lacks traditional fundamental metrics like P/E or revenue data, as it is an exchange-traded note tracking the FANG+ Index with 3x leverage.
The outlook for FNGU is highly speculative, driven by momentum in tech stocks but fraught with decay risks from daily rebalancing. Opportunities exist for short-term traders betting on Nasdaq-100 rallies, while risks include rapid capital erosion during market downturns, as evidenced by recent losses. Investors must understand the product's structure to avoid unintended losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About MicroSectors FANG and Innovation 3X Leveraged ETN
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →
